Not small and medium-sized enterprises. Renhe Pharmaceutical Co., Ltd. is a private enterprise, the actual controller is Yang Wenlong, and another major shareholder, Tigerson Yang, is the son of Wen Yang Dragon. They are people acting in concert, with a total equity ratio of 25.4438+0%. Renhe Pharmaceutical Co., Ltd. is a company located in Nanchang, Jiangxi Province, which mainly produces traditional Chinese medicine, chemical medicine and health food. ***49 pharmaceutical production lines have obtained national GMP certification, making them one of the enterprises with the largest number of GMP certification production lines in China. The company's main products are Renhe Kelik, Youkadan, Fuyanjie, Dahuoluo Pills, Shiny Eye Drops, Huo Qing Capsules and Kevin·Z Capsules. In 20 16, the annual sales reached 3.567 billion yuan, the net profit was 43 10/00000 yuan, the gross profit margin was 36.6 1%, the net interest rate was 12.08%, and the return on net assets was 14.84%. During the 1 1 year since the company went public, the share price rose by about 2.38 times, and the average annualized compound rate of return was 8.20%. The company's current market value is about 6.6 billion yuan. Renhe Pharmaceutical Co., Ltd. is a listed company listed on Shenzhen Stock Exchange. The company, formerly known as Jiujiang Chemical Fiber Co., Ltd., was approved by Jiangxi Provincial People's Government 1996 and 165438 on October 8, and was issued by China Securities Regulatory Commission with the word (1996) 365438+.